• Pipeline
• Post Marketing Commitments
• Clinical Trials
• Science Policy
  • Conducting Ethical Research
• R&D Locations
• Licensing, Development & Alliances
• Investigator-Initiated Research

Science Policy

Pfizer manages the world's largest pharmaceutical research effort, which includes more than 13,000 scientists worldwide, supported by $7.6 billion in funding during 2006.

We strive to maintain the highest ethical, scientific, and clinical standards in all our clinical research around the world. We regularly review our science policies to align them with Pfizer's vision, values, and goals, and with our stakeholders' evolving values.

A few facts about Pfizer:

• We conduct research and development in 19 major disease areas, which is more than any other company.
• In addition to Pfizer's internal clinical research principles, we follow the generally accepted international standards for research.
• All of our clinical research must be reviewed by a qualified Independent Ethics Committee or Institutional Review Board.
• Our clinical trials in host countries must be relevant to their health needs. For example, we work with the African Center for Clinical Trials, a nonprofit organization of African researchers working to attract foreign research.
• We work with more than 250 partners in academia and industry, providing access to novel research and development tools and data on emerging trends.

Learn more about Pfizer's commitment to conducting ethical research and review our science policies.

Learn more